创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

膜联蛋白A5在疾病诊断与新药开发中的应用前景

Application Prospect of Annexin A5 in Disease Diagnosis and Drug Discovery

  • 摘要: 人膜联蛋白A5已被广泛应用于体外细胞凋亡检测,此外,其还具有用于心血管类疾病和炎症性疾病等治疗的潜在价值。膜联蛋白A5具有多种生物学功能及潜在的应用前景,从结合磷脂酰丝氨酸到凋亡检测,再到参与细胞膜修复、炎症过程、抗凝血过程;从参与疾病发生发展,到体内凋亡造影,再到体内治疗或介导体内靶向治疗等。膜联蛋白A5表现出体外诊断、临床诊断和治疗用途等重要应用价值。综述膜联蛋白A5的结构特点、作用及其机制、临床应用,并对其现存问题和发展方向进行分析和展望。

     

    Abstract: Human annexin A5 has been widely used in in vitro detection of apoptosis and also has potential value in the treatment of cardiovascular diseases and inflammatory diseases. Annexin A5 has various biological functions and promising application potential, ranging from binding to phosphatidylserine to apoptosis detection, further to participating in membrane repair, inflammation and anticoagulation, and from participating in the occurrence and development of diseases to in vivo imaging of apoptosis, further to in vivo therapy or mediating in vivo targeted therapy, etc. In conclusion, annexin A5 has shown important applications in in vitro diagnosis, clinical diagnosis and treatment. The recent progresses in the study of the structure characteristics, functions and mechanisms as well as clinical applications of annexin A5 were summarized, and the current difficulties and future prospects were also discussed and analyzed.

     

/

返回文章
返回